Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory N Gan

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Medical Physics|June 14, 2024
Simultaneous dose and dose rate optimization via dose modifying factor modeling for FLASH effective doseJiangjun Ma, Yuting Lin, Min Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
International Journal of Radiation Oncology, Biology, Physics|February 27, 2007
Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancerSushil Beriwal, Gregory N Gan, Dwight E Heron, et al.
Arxiv|December 9, 2024
Multi-IMPT: a biologically equivalent approach to proton ARC therapyNimita Shinde, Yanan Zhu, Wei Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2019
Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patientsLaurie E Steffen, Jennifer S Cheavens, Kevin E Vowles, et al.
International Journal of Particle Therapy|May 28, 2026
Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc TherapyNimita Shinde, Yanan Zhu, Wei Wang, et al.
Head & Neck|May 9, 2020
Predicting salvage laryngectomy in patients treated with primary nonsurgical therapy for laryngeal squamous cell carcinoma using machine learningJoshua B Smith, Matthew Shew, Omar A Karadaghy, et al.
Chemotherapy|July 26, 2022
Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent ChemoradiotherapyRyan T Morse, Rohit G Ganju, Rishi Neeranjun, et al.
Molecular Carcinogenesis|September 24, 2021
Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancerDeri Morgan, Kiersten L Berggren, Colby D Spiess, et al.
Medical Physics|November 20, 2021
Simultaneous dose and dose rate optimization (SDDRO) of the FLASH effect for pencil-beam-scanning proton therapyHao Gao, Jiulong Liu, Yuting Lin, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Medical Physics|June 14, 2024
Simultaneous dose and dose rate optimization via dose modifying factor modeling for FLASH effective doseJiangjun Ma, Yuting Lin, Min Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
International Journal of Radiation Oncology, Biology, Physics|February 27, 2007
Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancerSushil Beriwal, Gregory N Gan, Dwight E Heron, et al.
Arxiv|December 9, 2024
Multi-IMPT: a biologically equivalent approach to proton ARC therapyNimita Shinde, Yanan Zhu, Wei Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2019
Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patientsLaurie E Steffen, Jennifer S Cheavens, Kevin E Vowles, et al.
International Journal of Particle Therapy|May 28, 2026
Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc TherapyNimita Shinde, Yanan Zhu, Wei Wang, et al.
Head & Neck|May 9, 2020
Predicting salvage laryngectomy in patients treated with primary nonsurgical therapy for laryngeal squamous cell carcinoma using machine learningJoshua B Smith, Matthew Shew, Omar A Karadaghy, et al.
Chemotherapy|July 26, 2022
Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent ChemoradiotherapyRyan T Morse, Rohit G Ganju, Rishi Neeranjun, et al.
Molecular Carcinogenesis|September 24, 2021
Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancerDeri Morgan, Kiersten L Berggren, Colby D Spiess, et al.
Medical Physics|November 20, 2021
Simultaneous dose and dose rate optimization (SDDRO) of the FLASH effect for pencil-beam-scanning proton therapyHao Gao, Jiulong Liu, Yuting Lin, et al.
Pageof 5